rs373394254

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM1BS2

The NM_000238.4(KCNH2):​c.3094C>T​(p.Arg1032Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000368 in 1,549,430 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1032G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

5
7
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:1

Conservation

PhyloP100: 0.209
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 13 uncertain in NM_000238.4
BS2
High AC in GnomAd4 at 11 AD,Digenic gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KCNH2NM_000238.4 linkuse as main transcriptc.3094C>T p.Arg1032Trp missense_variant 13/15 ENST00000262186.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KCNH2ENST00000262186.10 linkuse as main transcriptc.3094C>T p.Arg1032Trp missense_variant 13/151 NM_000238.4 P1Q12809-1
KCNH2ENST00000330883.9 linkuse as main transcriptc.2074C>T p.Arg692Trp missense_variant 9/111 Q12809-2
KCNH2ENST00000684241.1 linkuse as main transcriptn.3927C>T non_coding_transcript_exon_variant 11/13

Frequencies

GnomAD3 genomes
AF:
0.0000724
AC:
11
AN:
152016
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000970
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000955
AC:
14
AN:
146606
Hom.:
0
AF XY:
0.000101
AC XY:
8
AN XY:
79342
show subpopulations
Gnomad AFR exome
AF:
0.000149
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000736
Gnomad SAS exome
AF:
0.000177
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000181
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000329
AC:
46
AN:
1397294
Hom.:
0
Cov.:
35
AF XY:
0.0000421
AC XY:
29
AN XY:
689216
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000417
Gnomad4 SAS exome
AF:
0.000240
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000371
Gnomad4 OTH exome
AF:
0.000138
GnomAD4 genome
AF:
0.0000723
AC:
11
AN:
152136
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74388
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000972
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000982
ExAC
AF:
0.0000303
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Long QT syndrome 2 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Uncertain significance, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteJun 11, 2020Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as a VUS-3B. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan, exon 13. (N) 0251 - Variant is heterozygous. (N) 0302 - Variant is present in gnomAD <0.001 for a dominant condition: 0.0000843 (15 het, 0 hom). (P) 0309 - An alternative amino acid change at the same position has been observed in gnomAD: p.(Arg1032Gln): 0.0000341(5 het, 0 hom). (N) 0502 - Missense variant with conflicting in silico predictions and/or uninformative conservation. Major amino acid change. Low conservation. (N) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. C-terminus. (N) 0708 - Comparable variants have conflicting previous evidence for pathogenicity. In one patient with LQTS (PMID: 20541041). In one LQTS patient who also had a pathogenic variant (R420W) in RYR2, that was considered the cause. Also, considered conflicting evidence in Cardiodb.org (from PMID: 22581653). (N) 0803 - Low previous evidence of pathogenicity in unrelated individuals. Reported as a potential pathogenic variant in a patient who died a sudden death and who also had two other potential pathogenic variants, a nonsense variant in MYLK2 and a missense variant in SCN5A. (PMID: 28704380). Classified as Likely pathogenic in a patient with LQTS (PMID: 30530868). Previously observed once in our LQTS patient cohort at VCGS. Has been submitted to ClinVar once as a VUS and referred to as c.2074C>T; p.(Arg692Trp), due to a different transcript used. (P) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
Long QT syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthNov 20, 2023This missense variant replaces arginine with tryptophan at codon 1032 of the KCNH2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in East Asian individuals affected with sudden unexpected death (PMID: 28704380), long QT syndrome (PMID: 30530868), complex arrhythmias (PMID: 33764691), or suspected to be affected with epilepsy or cardiovascular diseases ((PMID: 31696929). This variant has been shown not to segregate with disease in one of the families (PMID: 33764691). This variant has also been identified in 15/177868 chromosomes (8/12424 East Asian chromosomes) in the general population by the Genome Aggregation Database (gnomAD). The elevated variant allele frequency in the general population indicates that this variant may not be disease-causing. However, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 13, 2024This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1032 of the KCNH2 protein (p.Arg1032Trp). This variant is present in population databases (rs373394254, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of KCNH2-related conditions (PMID: 28704380, 30530868, 31696929, 32508047). ClinVar contains an entry for this variant (Variation ID: 200522). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 15, 2023Variant summary: KCNH2 c.3094C>T (p.Arg1032Trp) results in a non-conservative amino acid change in the encoded protein sequence, altering a well conserved residue (HGMD). Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 9.5e-05 in 146606 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in KCNH2 causing Arrhythmia (9.5e-05 vs 0.0001), allowing no conclusion about variant significance. c.3094C>T has been reported in the literature in individuals affected with Arrhythmia, congenital long QT syndrome, or other conditions without evidence of cosegregation (Li_2020, Kwok_2018, Suktitlpak_2017, Luo_2020, Lin_2021). These reports do not provide unequivocal conclusions about association of the variant with Arrhythmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six submitters have provided clinical-significance assessments for this variant to ClinVar after 2014, and all laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Short QT syndrome type 1;C3150943:Long QT syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 16, 2021- -
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMay 01, 2023This missense variant replaces arginine with tryptophan at codon 1032 of the KCNH2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in East Asian individuals affected with sudden unexpected death (PMID: 28704380), long QT syndrome (PMID: 30530868), complex arrhythmias (PMID: 33764691), or suspected to be affected with epilepsy or cardiovascular diseases ((PMID: 31696929). This variant has been shown not to segregate with disease in one of the families (PMID: 33764691). This variant has also been identified in 15/177868 chromosomes (8/12424 East Asian chromosomes) in the general population by the Genome Aggregation Database (gnomAD). The elevated variant allele frequency in the general population indicates that this variant may not be disease-causing. However, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 29, 2023This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Uncertain
0.015
T
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
23
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.49
.;T
Eigen
Benign
0.14
Eigen_PC
Benign
0.033
FATHMM_MKL
Benign
0.31
N
LIST_S2
Uncertain
0.93
D;D
M_CAP
Pathogenic
0.83
D
MetaRNN
Uncertain
0.54
D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
1.8
.;L
MutationTaster
Benign
0.99
D;D;D
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-2.5
D;D
REVEL
Pathogenic
0.66
Sift
Benign
0.18
T;T
Sift4G
Uncertain
0.028
D;T
Polyphen
1.0
D;D
Vest4
0.50
MVP
0.78
MPC
0.69
ClinPred
0.30
T
GERP RS
4.1
Varity_R
0.25
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs373394254; hg19: chr7-150644474; API